Values as of: 2024-10-30
COMMON STOCK | Shell Companies |
Last Closing
USD 7.5Change
0.00 (0.00)%Market Cap
USD 0.07BVolume
100.00Analyst Target
N/AVerdict
Verdict
European Healthcare Acquisition & Growth Company B.V. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more companies or businesses. It focuses on acquiring companies or businesses in the healthcare sector with a focus on biotechnology and specialty pharma, pharma services, medical technology and medical devices, diagnostic and lab services, and bioinformatics, as well as life science tools subsectors in Europe. The company was incorporated in 2021 and is based in Munich, Germany.
Company Website : https://www.ehc-company.com
Currency: EUR
Country : Germany
| Symbol | Name | Price(Change) | Market Cap |
|---|---|---|---|
| T81:F | AQUILA ACQ.CORP. CL.A |
+0.01 (+0.94%) |
USD 0.14B |
| H4I:F | HAHN-IMMOBILIEN-BET |
+0.10 (+0.91%) |
USD 0.12B |
| GY0:F | RCF ACQ.CORP.CL.A -0001 |
N/A |
USD 0.11B |
| KN2:F | BRIG.M3 EUROP.ACQ.A-0001 |
N/A |
USD 0.11B |
| 4C4:F | NEW AMSTER.INV. N.V. EO 1 |
-0.05 (-0.61%) |
USD 0.05B |
| RCVR:F | SMG EUROPEAN RECOV. EO 1 |
N/A |
USD 0.03B |
| JV2:F | ALKEMY CAPITAL INV.LS-02 |
-0.05 (-5.32%) |
USD 7.76M |
| K85:F | GS CHAIN PLC -000167 |
N/A |
USD 4.32M |
| 5MM:F | EAST STAR RES.PLC LS-01 |
-0.01 (-92.86%) |
USD 3.63M |
| Z8E:F | AJAX RESOURCES PLC LS-01 |
-0.01 (-23.81%) |
USD 1.69M |
N/A
| Market Performance vs. Industry/Classification (Shell Companies) | Market Performance vs. Exchange | ||||||
| Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
| YTD | |||||||
| Capital Gain | -16.67% | 45% | F | 31% | F | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | -16.67% | 45% | F | 32% | F | ||
| Trailing 12 Months | |||||||
| Capital Gain | -17.58% | 50% | F | 27% | F | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | -17.58% | 50% | F | 27% | F | ||
| Trailing 5 Years | |||||||
| Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | N/A | N/A | N/A | N/A | N/A | ||
| Average Annual (5 Year Horizon) | |||||||
| Capital Gain | -5.09% | 38% | F | 30% | F | ||
| Dividend Return | -5.09% | 38% | F | 27% | F | ||
| Total Return | N/A | N/A | N/A | N/A | N/A | ||
| Risk Return Profile | |||||||
| Volatility (Standard Deviation) | 7.76% | 54% | F | 93% | A | ||
| Risk Adjusted Return | -65.55% | 54% | F | 16% | F | ||
| Market Capitalization | 0.07B | 67% | D+ | 28% | F | ||
| Target Price Action | Rating Action | Analyst | Rating | Price | Date |
|---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
The company had positive total free cash flow in the most recent four quarters.
The stock is trading high compared to its peers median on a price to book value basis.
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
